Skip to main content

Table 1 Esophageal carcinosarcoma treated with preoperative therapy

From: Preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal carcinosarcoma: a case report and review of the literature

First author Year Age Sex Stage Preoperative therapy Clinical response Pathological response Prognosis
Zuiki [23] 2009 50 Male II CRT (FP+62 Gy) PR ND 36 months alive
Zuiki [23] 2009 66 Male I CRT (FP+40.2 Gy) PR ND 19 months alive
Kobayashi [24] 2010 68 Male III CRT (S-1/CDDP+40 Gy) PR npCR 60 months alive
Kobayashi [24] 2010 64 Male III CRT (FP+38 Gy) SD npCR 11 months dead
Kuo [7] 2010 68 Male III CRT (ND) ND ND 27 months alive
Kuo [7] 2010 45 Male IV CRT (ND) ND ND 6 months alive
Kobayashi [25] 2015 69 Male II FP SD NC 60 months alive
Present case 2016 73 Male III DCF SD npCR 12 months alive
  1. CRT chemoradiotherapy, PR partial response, npCR near pathological complete response, SD stable disease, FP 5-fluorouracil and cisplatin, S-1/CDDP S-1 and cisplatin, NC no change, DCF docetaxel, cisplatin, and 5-fluorouracil, ND not described